http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33179812

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Comment
endingPage 2748
issn 1527-7755
0732-183X
issueIdentifier 25
pageRange 2742-2748
publicationName Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage 2742
bibliographicCitation Wei AH, Roboz GJ, Kantarjian HM. Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia. J Clin Oncol. 2021 Sep 01;39(25):2742–8. PMID: 34086506; PMCID: PMC9851684.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6d00d3aba027043e0cfebb59b17c883
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0384-3658
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7514-3298
date 2021-09-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/34086506
https://doi.org/10.1200/jco.21.00080
https://pubmed.ncbi.nlm.nih.gov/PMC9851684
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
https://portal.issn.org/resource/ISSN/1527-7755
https://portal.issn.org/resource/ISSN/0732-183X
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia
discusses http://id.nlm.nih.gov/mesh/M000614617
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0028488
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015470
http://id.nlm.nih.gov/mesh/D019086
hasSubjectTerm http://id.nlm.nih.gov/mesh/D013449
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579

Showing number of triples: 1 to 32 of 32.